Samsung Galaxy Watch
Samsung Galaxy Watch devices have been granted approval by the US FDA for the Health Monitor app’s irregular heart rhythm notification (IHGN) feature. The company claims that, along with the wearable’s electrocardiogram (ECG) capabilities, the feature can help identify signs of atrial fibrillation (AFib), a type of arrhythmia that can increase the risk of stroke, heart failure, and other complications.
In some cases, AFib can be asymptomatic. The Galaxy Watch’s BioActive Sensor can detect irregular heart rhythms in the background after the wearer activates the function in the Samsung Health Monitor app. The watch will alert the wearer to possible AFib activity, and suggest taking an ECG reading for a more accurate measurement. If signs of AFib are detected, the watch will urge the wearer to consult a doctor.
Samung Galaxy Watch New Features
Apple Watches have included the IHGN feature in some markets since 2019, but Samsung’s feature availability will depend on the market, carrier, model, and the paired smartphone. The IHGN feature will be included in Samsung’s One UI 5 Watch update and will be available on the next lineup of Galaxy Watch devices later this year. The feature will be available for Galaxy Watch 4 series and later models at a later date. Additionally, One UI 5 Watch will introduce new sleep monitoring functions and a personalized heart rate zone feature for workouts.
Samsung’s IHGN feature approval by the FDA is an exciting development for the wearable technology industry. The Galaxy Watch’s capabilities to monitor heart rhythms and detect signs of AFib could lead to early detection and treatment of potentially life-threatening conditions. It’s worth noting that while AFib can be asymptomatic, some common symptoms include heart palpitations, shortness of breath, and fatigue.
Samsung’s Features Compared to Apple
It’s also essential to note that while Samsung’s feature is similar to Apple’s, the availability of the IHGN feature will depend on the market, carrier, model, and paired smartphone. Users should confirm that the feature is available in their region before relying on it for medical diagnosis. The FDA’s approval is a significant step towards using wearable technology for medical purposes, but it’s always essential to consult a medical professional for a comprehensive diagnosis and treatment plan.
In conclusion, Samsung’s Galaxy Watch devices’ FDA approval for the Health Monitor app’s irregular heart rhythm notification (IHGN) feature is a significant development in the wearable technology industry. It could help identify early signs of atrial fibrillation, a potentially life-threatening condition. While the feature is similar to Apple’s IHGN, it’s worth noting that availability depends on various factors. It’s always essential to consult a medical professional for a comprehensive diagnosis and treatment plan.
GIPHY App Key not set. Please check settings